These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 15521431
1. Fort Dodge recalls ProHeart 6, citing FDA safety concerns. Advisory committee to review FDA findings. Kuehn BM. J Am Vet Med Assoc; 2004 Oct 15; 225(8):1157-8. PubMed ID: 15521431 [No Abstract] [Full Text] [Related]
2. The ProHeart debate. Curry-Galvin E. J Am Vet Med Assoc; 2005 Apr 15; 226(8):1280-1. PubMed ID: 15844407 [No Abstract] [Full Text] [Related]
3. Injectable heartworm preventive for dogs. FDA Consum; 2001 Apr 15; 35(4):4. PubMed ID: 11692888 [No Abstract] [Full Text] [Related]
4. Evaluation of efficacy of heartworm preventive products at the FDA. Hampshire VA. Vet Parasitol; 2005 Oct 24; 133(2-3):191-5. PubMed ID: 16099105 [Abstract] [Full Text] [Related]
6. Safety evaluation of moxidectin sustained-release injectable in 10-week-old puppies. Heaney K, Lindahl RG. Vet Parasitol; 2005 Oct 24; 133(2-3):227-31. PubMed ID: 16171949 [Abstract] [Full Text] [Related]
7. Postmarketing surveillance of rabies vaccines for dogs to evaluate safety and efficacy. Frana TS, Clough NE, Gatewood DM, Rupprecht CE. J Am Vet Med Assoc; 2008 Apr 01; 232(7):1000-2. PubMed ID: 18380615 [No Abstract] [Full Text] [Related]
8. ORA's role at FDA headquarters and in the field for product recalls. Whetstone SN. Food Drug Law J; 1998 Apr 01; 53(3):513-6. PubMed ID: 10346723 [No Abstract] [Full Text] [Related]
9. The FDA and drug safety: a proposal for sweeping changes. Furberg CD, Levin AA, Gross PA, Shapiro RS, Strom BL. Arch Intern Med; 2006 Oct 09; 166(18):1938-42. PubMed ID: 17030825 [Abstract] [Full Text] [Related]
10. Recalls. FDA, industry cooperate to protect consumers. Nordenberg T. FDA Consum; 1995 Oct 09; 29(8):24-7. PubMed ID: 10151838 [Abstract] [Full Text] [Related]
11. Leavitt: reforms will improve oversight and openness at FDA. FDA Consum; 2005 Oct 09; 39(3):37. PubMed ID: 16127819 [Abstract] [Full Text] [Related]
12. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. McCall JW. Vet Parasitol; 2005 Oct 24; 133(2-3):197-206. PubMed ID: 16198822 [Abstract] [Full Text] [Related]
13. Progress in FDA pharmacosurveillance. Keller WC. J Am Vet Med Assoc; 1996 Nov 01; 209(9):1546-7. PubMed ID: 8899014 [No Abstract] [Full Text] [Related]
14. FDA approves first canine diet drug. Nolen RS. J Am Vet Med Assoc; 2007 Mar 01; 230(5):641-2. PubMed ID: 17380625 [No Abstract] [Full Text] [Related]
15. Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned. Mathis LL, Iyasu S. Clin Pharmacol Ther; 2007 Aug 01; 82(2):133-4. PubMed ID: 17632537 [Abstract] [Full Text] [Related]
16. Challenges and opportunities in animal drug development: a regulatory perspective. Lathers CM. Nat Rev Drug Discov; 2003 Nov 01; 2(11):915-8. PubMed ID: 14560318 [No Abstract] [Full Text] [Related]
17. Drug approvals voluntarily withdrawn. J Am Vet Med Assoc; 2013 Oct 15; 243(8):1085. PubMed ID: 24236328 [No Abstract] [Full Text] [Related]
18. FDA fast-tracking of pet population control drugs. Weissinger J, McRae D. J Am Vet Med Assoc; 1991 Apr 01; 198(7):1231-3. PubMed ID: 2045345 [Abstract] [Full Text] [Related]
19. Report hits FDA to revamp safety oversight. Finkelstein JB. J Natl Cancer Inst; 2006 Jul 05; 98(13):884-5. PubMed ID: 16818849 [No Abstract] [Full Text] [Related]
20. New FDA reporting rule means new concerns. Healthc Hazard Mater Manage; 1996 Mar 05; 9(6):1-4. PubMed ID: 10155771 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]